Maito, Alfhaiser M.
HRN: 16-23-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/29/2023
06/04/2023
IV
1400mg
Q8
Pcap
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes